Skip to main content
. Author manuscript; available in PMC: 2009 Apr 28.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Mar;14(3):282–289. doi: 10.1016/j.bbmt.2007.12.488

Figure 2.

Figure 2

Cumulative incidence of (A) sustained donor engraftment, (B) acute grade 2-4 graft-versus-host disease (GVHD), and (C) chronic GVHD. The cumulative incidence of acute GVHD was comparable between the two graft sources, while that for donor engraftment and chronic GVHD was lower in UCB recipients.